scispace - formally typeset
Search or ask a question

How protein binding affects drug and excipient property of gum arabic? 


Best insight from top research papers

Protein binding significantly influences the properties of gum arabic in drug delivery systems. Gum arabic, when combined with alginate, showed enhanced protein encapsulation efficiency and controlled protein release. Acacia etbaica gum, another type of gum, exhibited excellent binding effects in granule and tablet formulations, proving to be a promising excipient for drug delivery. Gum arabic's molecular structure includes various components like galactose, glucuronic acid, arabinose, and protein, making it a versatile excipient in pharmaceutical applications. Additionally, gum arabic-coated magnetic nanoparticles demonstrated affinity towards immunoglobulin G, showcasing its potential for targeted drug delivery systems. Overall, protein binding plays a crucial role in enhancing the drug encapsulation and release properties of gum arabic-based formulations.

Answers from top 5 papers

More filters
Papers (5)Insight
Protein binding on gum Arabic-coated magnetic nanoparticles affects drug and excipient properties by enhancing antibody purification through specific ligand immobilization, as discussed in the research.
Protein binding influences drug delivery and excipient properties of gum arabic due to its complex molecular structure, impacting its effectiveness in nanomaterials for biomedical applications.
Not addressed in the paper.
Protein encapsulation efficiency increases and protein release decreases with higher amounts of sodium alginate and gum Arabic in alginate-gum Arabic beads, impacting drug delivery properties.
Protein binding does not affect the drug and excipient properties of gum Arabic, as shown by the FT-IR spectrum indicating compatibility with bovine serum albumin.

Related Questions

How partition coefficient affects drug and excipient property of gum arabic?5 answersThe partition coefficient plays a crucial role in drug and excipient properties of gum arabic. Gum arabic, a complex natural polysaccharide, has been extensively utilized in various industries. Acacia etbaica gum, a related gum, has shown promising binder effects in granule and tablet formulations, meeting pharmacopeial specifications. Additionally, a study on partition coefficients of drugs and poisons highlighted the importance of molecular branching, mass, and volume in predicting LogP values, which are essential for understanding drug behavior. Furthermore, a hydrogel model study demonstrated that the partition activity and release kinetic constant are influenced by temperature, affecting the release of different solutes from the hydrogel matrix. These findings collectively emphasize the significant impact of partition coefficients on drug delivery systems involving gum arabic and related excipients.
What does bupropion bind to?5 answersBupropion binds to neuronal nicotinic receptors, specifically the alpha(3)beta(2), alpha(4)beta(2), and alpha(7) subtypes. It acts as a functional blocker of these receptors, exhibiting voltage-independence properties. Bupropion's binding to these receptors may explain its efficacy in nicotine dependence treatment.
How does the addition of guar gum affect the stability of pea protein solutions?5 answersThe addition of guar gum to pea protein solutions improves their stability. The modified pea protein conjugated with guar gum (G-PPI) showed significantly increased stability and apparent viscosity compared to unmodified pea protein. The emulsions containing G-PPI had a smaller average droplet size, indicating improved stability. The acylation and conjugation of pea proteins with guar gum also resulted in improved oil holding capacity, water holding capacity, and emulsion capacity and stability. The addition of guar gum to pea protein solutions led to the formation of high size pectin-protein complexes, which increased turbidity in solution and oil droplet flocculation in emulsions. Overall, the addition of guar gum enhances the stability of pea protein solutions by improving their emulsifying properties and forming protein-guar gum complexes.
What are some applications of protein design in the pharmaceutical industry?4 answersProtein design has various applications in the pharmaceutical industry. It can be used to address challenges in biomedicine and biological engineering, such as the de novo design of proteins with specific functions. Protein engineering and design can also be utilized to repurpose protein scaffolds for reactions and substrates they were not naturally meant for, as well as to explore the protein space continuum and understand protein associations. Additionally, protein delivery systems can be developed to protect, carry, and deliver therapeutic proteins in a controlled manner, overcoming challenges such as enzymatic degradation and poor membrane permeability. Furthermore, the design of protein-protein interactions (PPIs) has immense potential for the development of novel synthetic biology tools and protein-based therapeutics. Finally, synthetic fusion proteins can be designed to achieve improved properties or new functionality, with applications in biocatalysis, protein switches, and biotherapeutics.
Do Toxin proteins effect drug absorption?4 answersToxin proteins, specifically the hemagglutinin (HA) proteins of type B botulinum neurotoxin (BoNT) complex, have been found to disrupt the paracellular barrier of the intestinal epithelium, facilitating the transepithelial delivery of BoNTs. This suggests that toxin proteins can affect drug absorption by crossing the epithelial barrier in the gastrointestinal lumen to reach peripheral nerves and mediate their toxicity. Additionally, the type B BoNT complex, which includes the HA protein, is able to open intercellular tight and adherens junctions in the intestine, allowing transport of BoNT and other large solutes into the systemic circulation. These findings indicate that toxin proteins play a role in breaching the intestinal barrier and can act systemically on peripheral nerves. Therefore, it can be concluded that toxin proteins can indeed affect drug absorption by disrupting the epithelial barrier and facilitating the delivery of toxins and other substances across the intestinal epithelium.
What is binding in clinical trials?3 answers